104 related articles for article (PubMed ID: 7014485)
1. [12-asparagine-B] human insulin. An analogue with modification in the hydrophobic core of insulin.
Schwartz GP; Burke GT; Katsoyannis PG
Int J Pept Protein Res; 1981 Feb; 17(2):243-55. PubMed ID: 7014485
[TBL] [Abstract][Full Text] [Related]
2. Divergence of the in vitro biological activity and receptor binding affinity of a synthetic insulin analogue, [21-asparaginamide-A]insulin.
Burke GT; Chanley JD; Okada Y; Cosmatos A; Ferderigos N; Katsoyannis PG
Biochemistry; 1980 Sep; 19(20):4547-56. PubMed ID: 7000179
[TBL] [Abstract][Full Text] [Related]
3. Nature of the B10 amino acid residue. Requirements for high biological activity of insulin.
Burke GT; Schwartz G; Katsoyannis PG
Int J Pept Protein Res; 1984 Apr; 23(4):394-401. PubMed ID: 6373642
[TBL] [Abstract][Full Text] [Related]
4. Steric requirements at position B12 for high biological activity in insulin.
Hu SQ; Burke GT; Schwartz GP; Ferderigos N; Ross JB; Katsoyannis PG
Biochemistry; 1993 Mar; 32(10):2631-5. PubMed ID: 8448120
[TBL] [Abstract][Full Text] [Related]
5. An insulin analogue possessing higher in vitro biological activity than receptor binding affinity. [21-Proline-B]insulin.
Schwartz GP; Burke GT; Chanley JD; Katsoyannis PG
Biochemistry; 1983 Sep; 22(19):4561-7. PubMed ID: 6354263
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of an insulin analogue embodying a strongly fluorescent moiety, [19-tryptophan-A]insulin.
Ohta N; Burke GT; Katsoyannis PG
J Protein Chem; 1988 Feb; 7(1):55-65. PubMed ID: 3076448
[TBL] [Abstract][Full Text] [Related]
7. A superactive insulin: [B10-aspartic acid]insulin(human).
Schwartz GP; Burke GT; Katsoyannis PG
Proc Natl Acad Sci U S A; 1987 Sep; 84(18):6408-11. PubMed ID: 3306677
[TBL] [Abstract][Full Text] [Related]
8. Superactive insulins.
Burke GT; Hu SQ; Ohta N; Schwartz GP; Zong L; Katsoyannis PG
Biochem Biophys Res Commun; 1990 Dec; 173(3):982-7. PubMed ID: 2268358
[TBL] [Abstract][Full Text] [Related]
9. The A14 position of insulin tolerates considerable structural alterations with modest effects on the biological behavior of the hormone.
Chu YC; Zong L; Burke GT; Katsoyannis PG
J Protein Chem; 1992 Oct; 11(5):571-7. PubMed ID: 1360216
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of invariant valine B12 in insulin: implications for receptor binding.
Nakagawa SH; Tager HS; Steiner DF
Biochemistry; 2000 Dec; 39(51):15826-35. PubMed ID: 11123908
[TBL] [Abstract][Full Text] [Related]
11. Effect of N-methylation of selected peptide bonds on the biological activity of insulin. [2-N-methylisoleucine-A]insulin and [3-N-methylvaline-A]insulin.
Ogawa H; Burke GT; Chanley JD; Katsoyannis PG
Int J Pept Protein Res; 1987 Oct; 30(4):460-73. PubMed ID: 3323092
[TBL] [Abstract][Full Text] [Related]
12. Interaction between the A2 and A19 amino acid residues is of critical importance for high biological activity in insulin: [19-leucine-A]insulin.
Kitagawa K; Ogawa H; Burke GT; Chanley JD; Katsoyannis PG
Biochemistry; 1984 Sep; 23(19):4444-8. PubMed ID: 6386048
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of human [9-leucine-B] Insulin.
Schwartz G; Katsoyannis PG
Biochemistry; 1976 Sep; 15(18):4071-76. PubMed ID: 963021
[TBL] [Abstract][Full Text] [Related]
14. Possible involvement of the A20-A21 peptide bond in the expression of the biological activity of insulin. 2. [21-Asparagine diethylamide-A]insulin.
Chu YC; Burke GT; Chanley JD; Katsoyannis PG
Biochemistry; 1987 Nov; 26(22):6972-5. PubMed ID: 3322394
[TBL] [Abstract][Full Text] [Related]
15. Possible involvement of the A20-A21 peptide bond in the expression of the biological activity of insulin. 1. [21-Desasparagine,20-cysteinamide-A]insulin and [21-desasparagine,20-cysteine isopropylamide-A]insulin.
Chu YC; Wang RY; Burke GT; Chanley JD; Katsoyannis PG
Biochemistry; 1987 Nov; 26(22):6966-71. PubMed ID: 3322393
[TBL] [Abstract][Full Text] [Related]
16. [21-arginine-A] insulin: a biologically active analog.
Ferderigos N; Cosmatos A; Ferderigos A; Katsoyannis PG
Int J Pept Protein Res; 1979 Jan; 13(1):43-53. PubMed ID: 422323
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of des(tetrapeptide B(1-4)) and des(pentapeptide B(1-5)) human insulins. Two biologically active analogues.
Schwartz G; Katsoyannis PG
Biochemistry; 1978 Oct; 17(21):4550-6. PubMed ID: 718857
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of two biologically active insulin analogues with modifications at the N-terminal and N- and C-terminal amino acid residues.
Cosmatos A; Okada Y; Katsoyannis PG
Biochemistry; 1976 Sep; 15(18):4076-82. PubMed ID: 963022
[TBL] [Abstract][Full Text] [Related]
19. [B22-D-arginine]insulin: synthesis and biological properties.
Knorr R; Danho W; Büllesbach EE; Gattner HG; Zahn H; King GL; Kahn CR
Hoppe Seylers Z Physiol Chem; 1982 Dec; 363(12):1449-60. PubMed ID: 6761262
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological activity of seventeen analogues of human insulin.
Märki F; de Gasparo M; Eisler K; Kamber B; Riniker B; Rittel W; Sieber P
Hoppe Seylers Z Physiol Chem; 1979 Nov; 360(11):1619-32. PubMed ID: 511097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
